These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37164265)
21. Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study. Greeshma LR; Joseph AP; Sivakumar TT; Raghavan Pillai V; Vijayakumar G Sci Rep; 2023 Dec; 13(1):21698. PubMed ID: 38066025 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis. Varun BR; Ranganathan K; Rao UK; Joshua E J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093 [TBL] [Abstract][Full Text] [Related]
23. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811 [TBL] [Abstract][Full Text] [Related]
24. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Girod SC; Pfeiffer P; Ries J; Pape HD Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452 [TBL] [Abstract][Full Text] [Related]
25. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables. Tan Y; Liu R; Xue JW; Feng Z Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828 [TBL] [Abstract][Full Text] [Related]
26. Malignant transformation rate of oral leukoplakia in an Australian population. Shearston K; Fateh B; Tai S; Hove D; Farah CS J Oral Pathol Med; 2019 Aug; 48(7):530-537. PubMed ID: 31172563 [TBL] [Abstract][Full Text] [Related]
27. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma. Wang QM; Huang XY; Guan WQ Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378 [TBL] [Abstract][Full Text] [Related]
28. Overestimated risk of transformation in oral lichen planus. Cai X; Zhang J; Zhang H; Li T Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493 [TBL] [Abstract][Full Text] [Related]
30. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP. Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603 [TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cell-exosome-mediated matrix metalloproteinase 1 participates in oral leukoplakia and carcinogenesis by inducing angiogenesis. Li S; Han Y; Lu M; Liu Z; Jin J; Guo Q; Wang Y; Liu H J Oral Pathol Med; 2022 Aug; 51(7):638-648. PubMed ID: 35792829 [TBL] [Abstract][Full Text] [Related]
33. DNA content abnormality in oral submucous fibrosis concomitant leukoplakia: A preliminary evaluation of the diagnostic and clinical implications. Xiao X; Hu Y; Li C; Shi L; Liu W Diagn Cytopathol; 2020 Nov; 48(11):1111-1114. PubMed ID: 32433822 [TBL] [Abstract][Full Text] [Related]
34. CircHLA-C: A significantly upregulated circRNA co-existing in oral leukoplakia and oral lichen planus. Yang J; Song Y; Xu S; Ge S; Haiwen Z Organogenesis; 2023 Dec; 19(1):2234504. PubMed ID: 37531467 [TBL] [Abstract][Full Text] [Related]
35. [Expression of Ki-67 and P53 protein in oral squamous cell carcinoma and its clinical significance]. He W; Xiao Y; Chen WM Shanghai Kou Qiang Yi Xue; 2015 Apr; 24(2):228-31. PubMed ID: 25938156 [TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia. Gouvêa AF; Vargas PA; Coletta RD; Jorge J; Lopes MA J Oral Pathol Med; 2010 Jul; 39(6):447-52. PubMed ID: 20412398 [TBL] [Abstract][Full Text] [Related]
37. Changes in apoptosis and mitotic index, p53 and Ki67 expression in various types of oral leukoplakia. Kövesi G; Szende B Oncology; 2003; 65(4):331-6. PubMed ID: 14707453 [TBL] [Abstract][Full Text] [Related]
38. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma. Yang SW; Lee YC; Lee YS; Chang LC; Lai YR Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786 [TBL] [Abstract][Full Text] [Related]
39. Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation. Farah CS; Jessri M; Bennett NC; Dalley AJ; Shearston KD; Fox SA Oral Oncol; 2019 Sep; 96():42-50. PubMed ID: 31422212 [TBL] [Abstract][Full Text] [Related]
40. MAGE-A expression in oral and laryngeal leukoplakia predicts malignant transformation. Baran CA; Agaimy A; Wehrhan F; Weber M; Hille V; Brunner K; Wickenhauser C; Siebolts U; Nkenke E; Kesting M; Ries J Mod Pathol; 2019 Jul; 32(8):1068-1081. PubMed ID: 30936424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]